
Global & Brazil Cancer Therapeutics Market to 2031
Description
Cancer is a major chronic health concern among Brazil’s elderly population. As reported by the Pan American Health Organization (PAHO), over 30 million Brazilians were aged 60 and above in 2022, accounting for approximately 13% of the population. This number is projected to increase to nearly 50 million by 2030, representing 24% of the total population. With a steadily aging population, Brazil is witnessing a surge in cancer incidence, particularly in cases of breast, prostate, and lung cancers. This demographic shift is expected to significantly increase the demand for effective cancer therapies in the coming years.
Data from GLOBOCAN 2020 shows that Brazil recorded 592,212 cancer cases, with 300,144 in men and 292,098 in women. Among these, breast cancer was one of the most frequently diagnosed types. The Brazilian National Cancer Institute (INCA) estimates that approximately 66,200 new breast cancer cases are identified in women each year. Additionally, colorectal cancer—more prevalent among the elderly—had around 55,102 new cases in 2020, based on GLOBOCAN data.
The Brazilian government has made substantial investments in strengthening the country’s healthcare system, enhancing access to oncology services. Institutions like INCA have been instrumental in advancing cancer care and research. These efforts, combined with a growing focus on early diagnosis and personalized treatments, are driving the growth of Brazil's cancer therapeutics market.
Data from GLOBOCAN 2020 shows that Brazil recorded 592,212 cancer cases, with 300,144 in men and 292,098 in women. Among these, breast cancer was one of the most frequently diagnosed types. The Brazilian National Cancer Institute (INCA) estimates that approximately 66,200 new breast cancer cases are identified in women each year. Additionally, colorectal cancer—more prevalent among the elderly—had around 55,102 new cases in 2020, based on GLOBOCAN data.
The Brazilian government has made substantial investments in strengthening the country’s healthcare system, enhancing access to oncology services. Institutions like INCA have been instrumental in advancing cancer care and research. These efforts, combined with a growing focus on early diagnosis and personalized treatments, are driving the growth of Brazil's cancer therapeutics market.
Table of Contents
100 Pages
- 1. Introduction
- 1.1 Report Guidance
- 1.2 Market Segmentation
- 2. Executive Summary
- 2.1 Key Insights
- 3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Data Triangulation and Validation:
- 4. Brazil Cancer Therapeutics Market Landscape
- 4.1 Overview
- 4.2 Ecosystem Analysis
- 4.2.1 List of Vendors in the Value Chain
- 5. Cancer Therapeutics Market Key Market Dynamics
- 5.1 Cancer Therapeutics Market – Key Market Dynamics
- 5.2 Market Drivers
- 5.3 Market Restraints
- 5.4 Market Opportunities
- 5.5 Future Trends
- 5.6 Impact of Drivers and Restraints
- 6. Brazil Cancer Therapeutics Market – Analysis
- 6.1 Brazil Cancer Therapeutics Market Revenue (US$ Million), 2021–2031
- 6.2 Brazil Cancer Therapeutics Market Revenue and Forecast Analysis
- 7. Brazil Cancer Therapeutics Market Analysis – by Therapy Types
- 7.1 Brazil Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types
- 8. Brazil Cancer Therapeutics Market Analysis – by Indications
- 8.1 Brazil Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications
- 9. Brazil Cancer Therapeutics Market Analysis – by Distribution Channel
- 9.1 Brazil Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel
- 10. Competitive Landscape
- 10.1 Heat Map Analysis by Key Players
- 10.1 Company Positioning and Concentration
- 11. Industry Landscape
- 11.1 Overview
- 11.2 Market Initiative
- 11.2 Partnerships and Collaborations
- 11.2 Other Developments
- 12. Company Profiles
- 12.1 Bristol-Myers Squibb Co
- 12.1. 1 Key Facts
- 12.1. 2 Business Description
- 12.1. 3 Products and Services
- 12.1. 4 Financial Overview
- 12.1. 5 SWOT Analysis
- 12.1. 6 Key Developments
- 12.2 AbbVie Inc
- 12.2. 1 Key Facts
- 12.2. 2 Business Description
- 12.2. 3 Products and Services
- 12.2. 4 Financial Overview
- 12.2. 5 SWOT Analysis
- 12.2. 6 Key Developments
- 12.3 Johnson & Johnson
- 12.3. 1 Key Facts
- 12.3. 2 Business Description
- 12.3. 3 Products and Services
- 12.3. 4 Financial Overview
- 12.3. 5 SWOT Analysis
- 12.3. 6 Key Developments
- 12.4 F. Hoffmann-La Roche Ltd
- 12.4. 1 Key Facts
- 12.4. 2 Business Description
- 12.4. 3 Products and Services
- 12.4. 4 Financial Overview
- 12.4. 5 SWOT Analysis
- 12.4. 6 Key Developments
- 12.5 Pfizer Inc
- 12.5. 1 Key Facts
- 12.5. 2 Business Description
- 12.5. 3 Products and Services
- 12.5. 4 Financial Overview
- 12.5. 5 SWOT Analysis
- 12.5. 6 Key Developments
- 12.6 AstraZeneca Plc
- 12.6. 1 Key Facts
- 12.6. 2 Business Description
- 12.6. 3 Products and Services
- 12.6. 4 Financial Overview
- 12.6. 5 SWOT Analysis
- 12.6. 6 Key Developments
- 12.7 Merck KGaA
- 12.7. 1 Key Facts
- 12.7. 2 Business Description
- 12.7. 3 Products and Services
- 12.7. 4 Financial Overview
- 12.7. 5 SWOT Analysis
- 12.7. 6 Key Developments
- 12.8 Novartis AG
- 12.8. 1 Key Facts
- 12.8. 2 Business Description
- 12.8. 3 Products and Services
- 12.8. 4 Financial Overview
- 12.8. 5 SWOT Analysis
- 12.8. 6 Key Developments
- 12.9 Astellas Pharma Inc
- 12.9. 1 Key Facts
- 12.9. 2 Business Description
- 12.9. 3 Products and Services
- 12.9. 4 Financial Overview
- 12.9. 5 SWOT Analysis
- 12.9. 6 Key Developments
- 12.10 Eli Lilly and Co
- 12.10. 1 Key Facts
- 12.10. 2 Business Description
- 12.10. 3 Products and Services
- 12.10. 4 Financial Overview
- 12.10. 5 SWOT Analysis
- 12.10. 6 Key Developments
- 13. Appendix
- 13.1 About Business Market Insights
- 13.2 List of Abbreviations
- TABLE OF TABLES
- Table 1. Brazil Cancer Therapeutics Market Segmentation
- Table 2. List of Vendors
- Table 3. Brazil Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)
- Table 4. Brazil Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)
- Table 5. Brazil Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types
- Table 6. Brazil Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types
- Table 7. Brazil Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications
- Table 8. Brazil Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications
- Table 9. Brazil Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel
- Table 10. Brazil Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel
- Table 11. List of Abbreviations
- TABLE OF FIGURES
- Figure 1. Impact Analysis of Drivers and Restraints
- Figure 2. Brazil Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031
- Figure 3. Heat Map Analysis by Key Players
- Figure 4. Company Positioning and Concentration
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.